Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SHPH | US
-0.04
-2.41%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
1.62
1.63
1.70
1.61
Shuttle Pharmaceuticals Holdings Inc. a clinical stage pharmaceutical company develops novel therapies to cure cancers. It develops Ropidoxuridine an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161 an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225 a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303 a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville Maryland.
View LessPrice Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
152.3%1 month
147.4%3 months
109.7%6 months
90.7%-
-
4.72
1.44
0.41
-0.67
-
-
-5.74M
3.61M
3.61M
-
-
-
-
-186.00
0.21
0.66
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.95
Range1M
2.02
Range3M
3.01
Rel. volume
0.04
Price X volume
105.13K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.83 | 3.93M | -10.93% | n/a | 8.44% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.61 | 3.74M | -3.33% | 0.07 | 0.00% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 4.44 | 3.64M | 4.72% | 0.04 | 187.62% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.3752 | 3.60M | 0.05% | n/a | 83.11% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.151 | 2.99M | -2.46% | n/a | -104.44% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.9607 | 2.45M | -3.93% | n/a | 4.26% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.651 | 2.26M | -5.65% | n/a | 19.00% |
Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0011 | 1.21M | n/a | -22.64% | |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.7525 | 881.21K | -9.34% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.1012 | 0 | -14.09% | n/a | 2.46% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.42 | 3.63M | 1.43% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.751 | 1.10M | 24.54% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 915.21K | -8.33% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.31 | 0 | 0.35% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.67 | 16.67 | Cheaper |
Ent. to Revenue | - | 309.37 | - |
PE Ratio | - | 29.14 | - |
Price to Book | 4.72 | 12.81 | Cheaper |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 109.69 | 75.12 | Riskier |
Debt to Equity | 1.44 | -0.93 | Expensive |
Debt to Assets | 0.41 | 0.45 | Par |
Market Cap | 3.61M | 5.22B | Emerging |